Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Laboratory of Pharmaceutical and Medical Chemistry, Gifu Pharmaceutical University, Gifu, Japan.
J Pharmacol Sci. 2024 Jun;155(2):44-51. doi: 10.1016/j.jphs.2024.04.001. Epub 2024 Apr 2.
Subretinal hemorrhages result in poor vision and visual field defects. During hemorrhage, several potentially toxic substances are released from iron-based hemoglobin and hemin, inducing cellular damage, the detailed mechanisms of which remain unknown. We examined the effects of excess intracellular iron on retinal pigment epithelial (RPE) cells. A Fe probe, SiRhoNox-1 was used to investigate Fe accumulation after treatment with hemoglobin or hemin in the human RPE cell line ARPE-19. We also evaluated the production of reactive oxygen species (ROS) and lipid peroxidation. Furthermore, the protective effect of-an iron chelator, 2,2'-bipyridyl (BP), and ferrostatin-1 (Fer-1) on the cell damage, was evaluated. Fe accumulation increased in the hemoglobin- or hemin-treated groups, as well as intracellular ROS production and lipid peroxidation. In contrast, BP treatment suppressed RPE cell death, ROS production, and lipid peroxidation. Pretreatment with Fer-1 ameliorated cell death in a concentration-dependent manner and suppressed ROS production and lipid peroxidation. Taken together, these findings indicate that hemoglobin and hemin, as well as subretinal hemorrhage, may induce RPE cell damage and visual dysfunction via intracellular iron accumulation.
视网膜下出血可导致视力下降和视野缺损。在出血过程中,铁基血红蛋白和胆绿素从血红蛋白中释放出几种潜在的有毒物质,诱导细胞损伤,其详细机制尚不清楚。我们研究了细胞内铁过量对视网膜色素上皮 (RPE) 细胞的影响。使用 Fe 探针 SiRhoNox-1 研究了血红蛋白或胆绿素处理后人类 RPE 细胞系 ARPE-19 中铁的积累情况。我们还评估了活性氧 (ROS) 和脂质过氧化的产生。此外,评估了铁螯合剂 2,2'-联吡啶 (BP) 和 Ferrostatin-1 (Fer-1) 对细胞损伤的保护作用。血红蛋白或胆绿素处理组的铁积累增加,细胞内 ROS 产生和脂质过氧化也增加。相比之下,BP 处理抑制了 RPE 细胞死亡、ROS 产生和脂质过氧化。Fer-1 的预处理以浓度依赖的方式改善细胞死亡,并抑制 ROS 产生和脂质过氧化。总之,这些发现表明血红蛋白和胆绿素以及视网膜下出血可能通过细胞内铁积累引起 RPE 细胞损伤和视觉功能障碍。